9-thiodeoxo-7-(thioacetamido)thiocolchicine | 123643-54-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 9-thiodeoxo-7-(thioacetamido)thiocolchicine
• 英文别名: N-(1,2,3-Trimethoxy-10-methylsulfanyl-9-thioxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-thioacetamide；N-[(7S)-1,2,3-trimethoxy-10-methylsulfanyl-9-sulfanylidene-6,7-dihydro-5H-benzo[a]heptalen-7-yl]ethanethioamide
• CAS: 123643-54-9
• 化学式: C₂₂H₂₅NO₃S₃
• 分子量: 447.643
• InChiKey: XFLUACCWASGIOF-INIZCTEOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  129
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  硫代秋水仙碱 在 劳森试剂 作用下， 以 甲苯 为溶剂， 反应 4.0h， 以8%的产率得到9-thiodeoxo-7-(thioacetamido)thiocolchicine
  参考文献：
  名称：

  Antitubulin effects of derivatives of 3-demethylthiocolchicine, methylthio ethers of natural colchicinoids, and thioketones derived from thiocolchicine. Comparison with colchicinoids

  摘要：

  Esterification of the phenolic group in 3-demethylthiocolchicine and exchange of the N-acetyl group with other N-acyl groups or a N-carbalkoxy group afforded many compounds which showed superior activity over the parent drug as inhibitors of tubulin polymerization and of the growth of L1210 murine leukemia cells in culture. A comparison of naturally occurring Colchicum alkaloids with thio isosters, obtained by replacing the OMe group at C(10) with a SCH3 group, showed the thio ethers to be invariably more potent in these assays. The comparison included 3-demethylthiodemecolcine prepared from 3-demethylthiocolchicine by partial synthesis. Thiation of thiocolchicine with Lawesson's reagent afforded novel thiotropolones which exhibited high antitubulin activity. Their structures are fully secured by spectral data. Colchicine and several of its analogues show good antitumor effect in mice infected with P388 lymphocytic leukemia, and all of them show high affinity for tubulin and inhibit tubulin polymerization at low concentration. Consequently, antitubulin assays with this class of compounds can serve as valuable prescreens for the initial evaluation of potential antitumor drugs.

  DOI：

  10.1021/jm00164a015